Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

967 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012].
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik K, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad Falez, Zeiher A; Avrupa Kardiyoloji Derneği (ESC) Akut ve Kronik Kalp Yetersizliği Tani ve Tedavisi 2012 Görev Grubu; ESC Kalp Yetersizliği Birliğinin Işbirliğiyle hazirlanmiştir; Heart Failure Association. McMurray JJ, et al. Among authors: maggioni ap. Turk Kardiyol Dern Ars. 2012 Oct;40 Suppl 3:77-137. Turk Kardiyol Dern Ars. 2012. PMID: 27305718 Turkish. No abstract available.
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators. Pfeffer MA, et al. Among authors: maggioni ap. N Engl J Med. 2003 Nov 13;349(20):1893-906. doi: 10.1056/NEJMoa032292. Epub 2003 Nov 10. N Engl J Med. 2003. PMID: 14610160 Free article. Clinical Trial.
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program.
Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJ, Olsson L, Rouleau JL, Young JB, Yusuf S. Ducharme A, et al. Among authors: maggioni ap. Am Heart J. 2006 May;151(5):985-91. doi: 10.1016/j.ahj.2005.06.036. Am Heart J. 2006. PMID: 16644318
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJ, Olsson L, Rouleau JL, Young JB, Olofsson B, Puu M, Yusuf S; CHARM Investigators. Ducharme A, et al. Among authors: maggioni ap. Am Heart J. 2006 Jul;152(1):86-92. Am Heart J. 2006. PMID: 16838426
Left bundle branch block as a risk factor for progression to heart failure.
Zannad F, Huvelle E, Dickstein K, van Veldhuisen DJ, Stellbrink C, Køber L, Cazeau S, Ritter P, Maggioni AP, Ferrari R, Lechat P. Zannad F, et al. Among authors: maggioni ap. Eur J Heart Fail. 2007 Jan;9(1):7-14. doi: 10.1016/j.ejheart.2006.04.011. Epub 2006 Aug 4. Eur J Heart Fail. 2007. PMID: 16890486 Free article. Review.
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).
Anavekar NS, Skali H, Bourgoun M, Ghali JK, Kober L, Maggioni AP, McMurray JJ, Velazquez E, Califf R, Pfeffer MA, Solomon SD. Anavekar NS, et al. Among authors: maggioni ap. Am J Cardiol. 2008 Mar 1;101(5):607-12. doi: 10.1016/j.amjcard.2007.09.115. Am J Cardiol. 2008. PMID: 18308007 Clinical Trial.
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, Rouleau JL, Maggioni AP, Swedberg K, Kober L, White H, Dalby AJ, Francis GS, Zannad F, Califf RM, Pfeffer MA. Lewis EF, et al. Among authors: maggioni ap. Eur Heart J. 2008 Mar;29(6):748-56. doi: 10.1093/eurheartj/ehn062. Epub 2008 Feb 28. Eur Heart J. 2008. PMID: 18308687 Clinical Trial.
Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study.
Meris A, Amigoni M, Uno H, Thune JJ, Verma A, Køber L, Bourgoun M, McMurray JJ, Velazquez EJ, Maggioni AP, Ghali J, Arnold JM, Zelenkofske S, Pfeffer MA, Solomon SD. Meris A, et al. Among authors: maggioni ap. Eur Heart J. 2009 Jan;30(1):56-65. doi: 10.1093/eurheartj/ehn499. Epub 2008 Nov 11. Eur Heart J. 2009. PMID: 19001474
Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT).
Berry C, Pieper KS, White HD, Solomon SD, Van de Werf F, Velazquez EJ, Maggioni AP, Califf RM, Pfeffer MA, McMurray JJ. Berry C, et al. Among authors: maggioni ap. Eur Heart J. 2009 Jun;30(12):1450-6. doi: 10.1093/eurheartj/ehp102. Epub 2009 Apr 3. Eur Heart J. 2009. PMID: 19346225 Clinical Trial.
967 results